Sign inGet started

Praill Scott

Insider CIK 1332948 · DMPI Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KTRA Kintara Therapeutics, Inc. A Award deriv2022-08-012022-08-03720,260— $0720,260SEC↗
KTRA Kintara Therapeutics, Inc. A Award2022-08-012022-08-03240,087— $0277,273SEC↗
KTRA Kintara Therapeutics, Inc. P Buy2021-12-082021-12-0928,700$0.68 $19.5K37,186SEC↗
KTRA Kintara Therapeutics, Inc. C Conversion deriv2021-04-292021-04-293,750— $00SEC↗
KTRA Kintara Therapeutics, Inc. C Conversion2021-04-292021-04-29938— $08,486SEC↗
KTRA Kintara Therapeutics, Inc. J Other2021-04-292021-04-298— $07,548SEC↗
KTRA Kintara Therapeutics, Inc. J Other2021-03-312021-03-3122— $07,540SEC↗
KTRA Kintara Therapeutics, Inc. J Other2020-12-312021-01-0422— $07,518SEC↗
KTRA Kintara Therapeutics, Inc. J Other2020-09-302020-09-3022— $07,496SEC↗
KTRA Kintara Therapeutics, Inc. A Award deriv2020-09-152020-09-17606,557— $0606,557SEC↗
DMPI DelMar Pharmaceuticals, In J Other2020-06-302020-06-3022— $07,474SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2020-06-262020-06-3057,170— $0108,366SEC↗
DMPI DelMar Pharmaceuticals, In J Other2020-03-312020-03-3122— $07,452SEC↗
DMPI DelMar Pharmaceuticals, In J Other2019-12-312020-01-0222— $07,430SEC↗
DMPI DelMar Pharmaceuticals, In J Other2019-09-302019-10-0122— $07,408SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2019-09-052019-09-0957,170— $057,170SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2019-09-052019-09-0951,196— $051,196SEC↗
DMPI DelMar Pharmaceuticals, In J Other2019-06-282019-07-0122— $07,386SEC↗
DMPI DelMar Pharmaceuticals, In J Other2019-03-292019-04-01211$0.49 $10373,632SEC↗
DMPI DelMar Pharmaceuticals, In J Other2018-12-312019-01-02211$0.34 $7273,421SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2018-11-082018-11-13100,000— $0100,000SEC↗
DMPI DelMar Pharmaceuticals, In J Other2018-09-282018-10-01211$3.20 $67573,210SEC↗
DMPI DelMar Pharmaceuticals, In J Other2018-06-292018-07-03211$3.20 $67572,999SEC↗
DMPI DelMar Pharmaceuticals, In J Other2018-03-302018-04-03211$3.20 $67572,788SEC↗
DMPI DelMar Pharmaceuticals, In C Conversion deriv2017-12-312018-01-0325,000$2.00 $50.0K0SEC↗
DMPI DelMar Pharmaceuticals, In J Other2017-12-312018-01-03211$3.20 $67547,577SEC↗
DMPI DelMar Pharmaceuticals, In C Conversion2017-12-312018-01-0325,000— $072,577SEC↗
DMPI DelMar Pharmaceuticals, In P Buy2017-10-052017-10-0517,500$0.85 $14.9K47,366SEC↗
DMPI DelMar Pharmaceuticals, In J Other2017-09-292017-10-02211$3.20 $67529,866SEC↗
DMPI DelMar Pharmaceuticals, In J Other2017-06-302017-07-05211$3.20 $67529,655SEC↗
DMPI DelMar Pharmaceuticals, In P Buy2017-06-262017-06-284,167$3.60 $15.0K29,444SEC↗
DMPI DelMar Pharmaceuticals, In P Buy2017-06-062017-06-069,500$2.10 $19.9K25,277SEC↗
DMPI DelMar Pharmaceuticals, In J Other2017-03-312017-04-03211$3.20 $67515,777SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2017-02-172017-02-2237,400— $037,400SEC↗
DMPI DelMar Pharmaceuticals, In J Other2016-12-312017-01-03211$3.20 $67515,566SEC↗
DMPI DelMar Pharmaceuticals, In J Other2016-10-032016-10-04211$3.20 $67515,355SEC↗
DMPI DelMar Pharmaceuticals, In J Other2016-07-182016-07-19144$3.20 $46115,144SEC↗
DMPI DelMar Pharmaceuticals, In P Buy deriv2016-04-292016-05-033,750$8.00 $30.0K3,750SEC↗
DMPI DelMar Pharmaceuticals, In P Buy deriv2015-07-162015-07-1650,000— $050,000SEC↗
DMPI DelMar Pharmaceuticals, In P Buy2015-07-162015-07-1650,000$0.60 $30.0K60,000SEC↗
DMPI DelMar Pharmaceuticals, In P Buy2014-03-182014-03-2010,000$1.30 $13.0K10,000SEC↗
DMPI DelMar Pharmaceuticals, In A Award deriv2013-08-162013-08-20350,000— $0350,000SEC↗